NCT00815633View on ClinicalTrials.gov

A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris

PHASE4TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

March 31, 2010

Conditions

Pityriasis Rubra Pilaris

Interventions

DRUG

Alefacept

15mg intramuscular injection weekly for 12 weeks

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Joshua Zeichner

OTHER